Literature DB >> 17362440

Acute confusional state after designer tryptamine abuse.

Masanari Itokawa1, Ken Iwata, Misako Takahashi, Gen-Ichi Sugihara, Takeshi Sasaki, Yu-Ichiro Abe, Minari Uno, Mizue Hobo, Daisuke Jitoku, Kikue Inoue, Makoto Arai, Ichiro Yasuda, Masahiro Shintani.   

Abstract

A 23-year-old Japanese woman was brought to the emergency department about 6.5 h after taking liquid and later a half tablet purchased on the street. About 4.5 h prior to presentation, she displayed excited and disorganized behavior. On examination, she was not alert or oriented, with a Glasgow Coma Scale score of 13, did not answer any questions from doctors while smirking and looking around restlessly, and sometimes exhibited echolalia, imitating the speech of doctors. She was given intravenous infusion of fluid for 8 h, then discharged. Gas chromatography-mass spectrometry of urine revealed 5-methoxy-diisopropyltryptamine, 5-methoxy-N-methyltryptamine and an unidentified tryptamine. Identifying chemical products based solely on information of users is insufficient, and urinalysis is necessary in cases potentially involving designer drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362440     DOI: 10.1111/j.1440-1819.2007.01638.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  3 in total

1.  Dual actions of 5-MeO-DIPT at the serotonin transporter and serotonin 5-HT1A receptor in the mouse striatum and prefrontal cortex.

Authors:  Yoko Hagino; Frank Scott Hall; George R Uhl; Ichiro Sora; Kazutaka Ikeda
Journal:  Neuropsychopharmacol Rep       Date:  2021-02-06

2.  Prolonged delusional state triggered by repeated ingestion of aromatic liquid in a past 5-methoxy-N, N-diisopropyltryptamine abuser.

Authors:  Yasuko Fuse-Nagase; Toru Nishikawa
Journal:  Addict Sci Clin Pract       Date:  2013-04-11

Review 3.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.